NS
Neeraj Srivastava
About Neeraj Srivastava
Data last updated:
Neeraj Srivastava is a Director at Segmed Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Segmed Pharmaceuticals Private Limited reported revenue of ₹5.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jan 2020 | 2020 | ₹5.4 Lakh (FY 2024) | Active |
Board colleagues of Neeraj Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pawan Kumar Singh | 08680162 | Segmed Pharmaceuticals Private Limited | Director |
| Shailendra Kumar Dwivedi | 08680173 | Segmed Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neeraj Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neeraj Srivastava
Neeraj Srivastava currently holds 1 directorship: Segmed Pharmaceuticals Private Limited (Director, since 27 Jan 2020, revenue ₹5.4 Lakh (FY 2024)).
Neeraj Srivastava was first appointed on 27 Jan 2020 as Director at Segmed Pharmaceuticals Private Limited.
The current boards of Neeraj Srivastava's companies include Pawan Kumar Singh (Segmed Pharmaceuticals Private Limited), Shailendra Kumar Dwivedi (Segmed Pharmaceuticals Private Limited).